8 results on '"Robert T. Gilson"'
Search Results
2. Tanning Attitudes and Behaviors in Adolescents and Young Adults
- Author
-
Daniel C. Glade, Robert T. Gilson, Valerie T. Fisher-Shiu, and Austin C. Smith
- Subjects
Adult ,Health Knowledge, Attitudes, Practice ,Skin Neoplasms ,integumentary system ,Adolescent ,Sunbathing ,business.industry ,Sun protection ,Health Behavior ,Sunburn ,medicine.disease ,Sun safety ,Young Adult ,Environmental health ,Skin Cancer Prevention ,Medicine ,Humans ,Skin cancer ,Young adult ,business ,Sunscreening Agents - Abstract
Skin cancer rates have been steadily increasing over the last 20 years despite persistent efforts to educate the public on skin cancer prevention and sun safety. Adolescents and young adults are an especially important demographic to reach, as increased UV exposure during these years leads to greatly increased risks of developing skin cancer. Our survey aims to investigate the attitudes and behaviors regarding sun protection and tanning among adolescents and young adults (age range, 13-27 years).
- Published
- 2021
3. Asymptomatic Hemorrhagic Lesions in an Anemic Woman
- Author
-
Margaret Brown, Robert T. Gilson, Zachary Gillooly, and Kavina Patel
- Subjects
Pediatrics ,medicine.medical_specialty ,Text mining ,business.industry ,Medicine ,medicine.symptom ,business ,Asymptomatic - Published
- 2021
4. Dapsone for Recalcitrant Eosinophilic Annular Erythema: A Case Report and Literature Review
- Author
-
Robert T. Gilson, Robert Christopher Gilson, and Luke Wallis
- Subjects
medicine.medical_specialty ,Annular erythema ,Case Report ,Dermatology ,Disease ,Treatment resistance ,Dapsone ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Eosinophilic ,Erythematous plaque ,Eosinophilia ,medicine ,Figurate erythema ,business.industry ,medicine.disease ,Hypersensitivity reaction ,030220 oncology & carcinogenesis ,Wells syndrome ,Etiology ,medicine.symptom ,business ,medicine.drug - Abstract
Eosinophilic annular erythema (EAE) is a rare entity of unknown etiology that is possibly related to a hypersensitivity reaction and presents as annular erythematous plaques with tissue eosinophilia. It is classified as a figurate erythema with a controversial relationship to Wells syndrome (WS) in the literature, where it is generally considered a separate entity or subset based on clinical and histopathologic differences. EAE typically presents with recurrent, erythematous, arcuate, and annular plaques on the trunk and proximal extremities. The course of the disease is often chronic, recurrent, and relapsing. Responses to treatment are variable but are typically best with systemic steroids and antimalarials. We report a patient refractory to other therapies who had a striking response to dapsone.
- Published
- 2017
5. An uncommon presentation of an uncommon disease: relapsing polychondritis overlap with systemic lupus erythematosus
- Author
-
Michelle A, Nguyen, Sahand, Rahnama-Moghadam, and Robert T, Gilson
- Subjects
Fever ,Humans ,Female ,Polychondritis, Relapsing ,Middle Aged ,Ear Diseases ,Lupus Nephritis ,Oral Ulcer ,Facial Dermatoses - Abstract
Relapsing polychondritis (RP) is a rare rheumatologic disorder in which recurrent episodes of inflammation result in destruction of cartilage of the ears and nose. The joints, eyes, audio-vestibular system, heart valves, respiratory tract, kidneys, and skin can also be involved. Skin involvement is most frequently linked to concomitant myelodysplastic syndrome and has rarely been associated with systemic lupus erythematosus. A 47-year-old woman presented with violaceous, indurated, tender plaques on the bilateral cartilaginous ears with sparing of the lobes, consistent with RP. Further investigations revealed positive ANA and anti-Smith antibody, oral ulcers, a photo-distributed skin eruption, and biopsy-proven lupus nephritis, leading to a second concomitant diagnosis of systemic lupus erythematosus (SLE). The diagnosis of SLE associated with RP was made and the patient was started on oral prednisone and hydroxychloroquine. This is a rare report of SLE associated with RP. It is unclear whether RP occurring in patients with SLE represents another clinical manifestation of SLE or a coexisting disease. However, a significant ANA titer in a patient with RP strongly suggests the presence of an associated autoimmune disorder. If immunologic abnormalities usually found in SLE are detected in patients with RP, it is important to monitor patients for the development of other manifestations of SLE.
- Published
- 2016
6. An uncommon presentation of an uncommon disease: relapsing polychondritis overlap with systemic lupus erythematosus
- Author
-
Sahand Rahnama-Moghadam, Robert T. Gilson, and Michelle A. Nguyen
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,Lupus nephritis ,Hydroxychloroquine ,Dermatology ,General Medicine ,Relapsing polychondritis, systemic lupus erythematosus, ANA ,medicine.disease ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Prednisone ,immune system diseases ,Rheumatologic Disorder ,Concomitant ,medicine ,business ,skin and connective tissue diseases ,030217 neurology & neurosurgery ,Nose ,Relapsing polychondritis ,medicine.drug ,Anti-SSA/Ro autoantibodies - Abstract
Relapsing polychondritis (RP) is a rare rheumatologic disorder in which recurrent episodes of inflammation result in destruction of cartilage of the ears and nose. The joints, eyes, audio-vestibular system, heart valves, respiratory tract, kidneys, and skin can also be involved. Skin involvement is most frequently linked to concomitant myelodysplastic syndrome and has rarely been associated with systemic lupus erythematosus. A 47-year-old woman presented with violaceous, indurated, tender plaques on the bilateral cartilaginous ears with sparing of the lobes, consistent with RP. Further investigations revealed positive ANA and anti-Smith antibody, oral ulcers, a photo-distributed skin eruption, and biopsy-proven lupus nephritis, leading to a second concomitant diagnosis of systemic lupus erythematosus (SLE). The diagnosis of SLE associated with RP was made and the patient was started on oral prednisone and hydroxychloroquine. This is a rare report of SLE associated with RP. It is unclear whether RP occurring in patients with SLE represents another clinical manifestation of SLE or a coexisting disease. However, a significant ANA titer in a patient with RP strongly suggests the presence of an associated autoimmune disorder. If immunologic abnormalities usually found in SLE are detected in patients with RP, it is important to monitor patients for the development of other manifestations of SLE.
- Published
- 2016
7. Syphilis: a reemerging infection
- Author
-
Peter L, Mattei, Thomas M, Beachkofsky, Robert T, Gilson, and Oliver J, Wisco
- Subjects
Male ,Coinfection ,Syphilis, Congenital ,HIV Infections ,Penicillin G ,United States ,Anti-Bacterial Agents ,Syphilis, Latent ,Neurosyphilis ,Pregnancy ,Disease Progression ,Humans ,Female ,Syphilis - Abstract
Rates of primary and secondary syphilis have increased in the past decade, warranting renewed attention to the diagnosis and treatment of this disease. Men who have sex with men are particularly affected; however, increases in infection rates have also been noted in women, as well as in all age groups and ethnicities. Physicians need to vigilantly screen high-risk patients. The concurrent rise in congenital syphilis also requires special attention and reemphasizes the need for continued early prenatal care and syphilis screening for all pregnant women. Syphilis infection in patients coinfected with human immunodeficiency virus has also become more common. New experimental diagnostic approaches, including using the B cell chemoattractant chemokine (CXC motif) ligand 13 as a cerebrospinal fluid marker, may help identify suspected neurosyphilis cases. Additionally, point-of-care immunochromatographic strip testing has been suggested for screening high-risk populations in developing countries. Nontreponemal screening tests followed by treponemal confirmatory tests continue to be standard diagnostics; however, interpreting false-negative and false-positive test results, and identifying serofast reactions, can be challenging. Although doxycycline, tetracycline, ceftriaxone, and azithromycin have been used to successfully treat syphilis, penicillin remains the drug of choice in all stages of infection and is the therapy recommended by the Centers for Disease Control and Prevention. Close follow-up is necessary to ensure treatment success.
- Published
- 2012
8. Bullous Pseudomonas skin infection and bacteremia caused by tattoo ink used in radiation therapy
- Author
-
Robert C. Gilson, Catherine M. Pham, and Robert T. Gilson
- Subjects
tattoo ,medicine.medical_specialty ,medicine.medical_treatment ,Dermatology ,Skin infection ,Tattoo ink ,New england ,Pseudomonas infection ,Pseudomonas ,medicine ,ink ,Case Series ,bacteremia ,business.industry ,FDA, US Food and Drug Administration ,Outbreak ,Methylprednisolone acetate ,medicine.disease ,infection ,Surgery ,Radiation therapy ,radiation ,bullous ,Bacteremia ,business - Abstract
The dangers of injection-related procedures came to light nationally with the 2012 outbreak of more than 750 fungal infections linked to the use of 3 recalled lots of preservative-free methylprednisolone acetate distributed by the New England Compounding Center.1 We describe a case of a life-threatening pseudomonas infection, which was traced to the ink used in placement of radiation tattoos. There are numerous reported infections related to recreational tattoo placement, but to our knowledge, this is the first report in the literature of a medical radiation tattoo–related infection.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.